Above Food Ingredients Inc. (ABVEW) 주식 분석

회사 개요

Above Food Ingredients Inc. (ABVEW) operates as a regenerative ingredient company with a vertically integrated supply chain spanning operations in Canada, the United States, Mexico, China, France, Turkey, and international markets. The firm conducts its business through two primary segments: Disruptive Agriculture and Rudimentary Ingredients, alongside a Consumer Products division. While the specific sector and industry classifications are not currently disclosed in available data, the company's operational footprint suggests a focus on sustainable agricultural inputs and consumer-facing product lines. The company's scale is characterized by a reported annual revenue of $294.84 million and a market capitalization that is not explicitly quantified in the current dataset, alongside an unlisted employee count. The absence of a disclosed market cap figure in the provided facts makes it difficult to directly compare the company's valuation against peers without external market data, though the revenue figure indicates a mid-to-large scale operational entity within the ingredient production space.

재무 건전성

The company reported a Total Revenue of $294.84 million for the trailing twelve months, yet this revenue generated a Net Income of -$61,292,864 and an EBITDA of -$40,343,004. The substantial gap between the positive revenue of $294.84 million and the significant net loss of approximately $61.3 million reveals a cost structure where operating expenses and losses heavily outweigh gross revenues, resulting in an overall unprofitable financial position. Although Free Cash Flow data is not available in the provided facts, the reported Cash balance of $664,430 against a Debt load of $133.84 million indicates a significant liquidity constraint that limits immediate financial flexibility for strategic acquisitions or heavy capital expenditures. Analysis of the three key margins shows a Gross Margin of -2.8%, an Operating Margin of -23.3%, and a Profit Margin of -23.4%, all of which indicate that the company is losing money on every unit sold and on every dollar of sales generated. The company holds $664,430 in cash but carries $133.84 million in debt, resulting in a Price to Book ratio of -0.48 which reflects the negative equity position relative to market valuation. The balance sheet is highly leveraged and distressed, as the cash on hand covers only a fraction of the outstanding debt obligations. Furthermore, the Current Ratio stands at 0.23, which signifies that the company's current assets are insufficient to cover its current liabilities, indicating a severe short-term liquidity risk. Return on Equity and Return on Assets metrics are not calculable due to the negative equity and asset base, preventing a traditional assessment of management effectiveness in generating returns for shareholders or utilizing assets efficiently.

밸류에이션 평가

The Trailing Twelve Months P/E Ratio and Forward P/E Ratio are both unavailable in the provided data, likely due to the company's negative earnings, which prevents the calculation of a standard earnings-based valuation multiple. The Price to Book ratio is listed at -0.48, which indicates that the market is valuing the company at a significant discount to its book value, or conversely, that the book value is negative, suggesting the market price is below the accounting net assets. Since Price to Sales and EV/EBITDA multiples are not provided in the facts, alternative valuation metrics to assess the company's intrinsic value relative to sales or enterprise earnings are not available for analysis. The stock has traded between a 52-week high of $0.28 and a 52-week low of $0.10, meaning the current price sits somewhere within this compressed range, reflecting high volatility typical of micro-cap or distressed securities. The Beta is 0.13, which implies that the stock's price volatility is significantly lower than the broader market, moving only one-thirteenth as much as the market index on average. This low beta suggests that the stock may not provide the expected market premium for risk-taking and could behave more like a low-correlation hedge, although its negative financials complicate the risk-return profile significantly.

Growth & Income

Revenue growth year-over-year stands at -45.0%, while Earnings Growth is not available due to the negative earnings history. The negative revenue growth indicates a contraction in sales volume or pricing power, and without positive earnings growth to offset this, the company is facing a dual challenge of shrinking top-line revenue and expanding losses. Since the company is not a dividend payer, as indicated by the unavailable dividend yield and payout ratio, it does not distribute cash to shareholders, and instead, the available cash is likely being retained to service debt or fund operations. The overall growth and income profile is characterized by significant revenue contraction, negative profitability across all margins, and a lack of dividend income, presenting a challenging outlook for income-oriented investors or those seeking capital appreciation through organic growth.